RARRES2 and obesity disorder: Supporting the important roles of chemerin in systemic lipid and glucose metabolism, accumulating clinical data indicate that local and/or circulating chemerin levels are increased in patients with obesity, diabetes and cardiovascular disease (Perumalsamy et al. 2017).